STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. GALT
  4. [ARS] GALECTIN THERAPEUTICS INC SEC Filing

[ARS] GALECTIN THERAPEUTICS INC SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - GALECTIN THERAPEUTICS INC

ARS Filing - GALECTIN THERAPEUTICS INC

This filing is available as a PDF document.

Filing Type: ARS

Company: GALECTIN THERAPEUTICS INC (GALT)

Acceptance Date: 2025-10-22T08:01:40.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock GALT logo
Galectin Therapeutics Inc

NASDAQ:GALT

GALT Rankings

#3769 Ranked by Market Cap
N/A Ranked by Dividends

GALT Latest News

Nov 14, 2025
Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update
Nov 10, 2025
Galectin Therapeutics Presented NAVIGATE Trial Results at the American Association for the Study of Liver Diseases (AASLD) 2025 Annual Meeting
Oct 20, 2025
Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference
Oct 7, 2025
Galectin Therapeutics to Present at the American Association for the Study of Liver Disease (AASLD) Liver Meeting 2025
Sep 2, 2025
Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

GALT Latest SEC Filings

Dec 8, 2025
[8-K] GALECTIN THERAPEUTICS INC Reports Material Event
Nov 19, 2025
[Form 4] GALECTIN THERAPEUTICS INC Insider Trading Activity
Nov 19, 2025
[Form 4] GALECTIN THERAPEUTICS INC Insider Trading Activity
Nov 14, 2025
[8-K] GALECTIN THERAPEUTICS INC Reports Material Event
Nov 14, 2025
[10-Q] GALECTIN THERAPEUTICS INC Quarterly Earnings Report

GALT Stock Data

368.14M
45.42M
30.08%
16.46%
12.47%
Biotechnology
Pharmaceutical Preparations
Link
United States
NORCROSS